Prospective trial of high-dose chemotherapy followed by infusions of peripheral blood stem cells and dose-escalated donor lymphocytes for relapsed leukemia after allogeneic stem cell transplantation.
about
New approaches to manipulate minimal residual disease after allogeneic stem cell transplantation.Intentional donor lymphocyte-induced limited acute graft-versus-host disease is essential for long-term survival of relapsed acute myeloid leukemia after allogeneic stem cell transplantation.Clinical options after failure of allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies.New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future.Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors.High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia--is more better or more of the same?5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis.Repeated donor lymphocyte infusions overcome a myeloid sarcoma of the stomach resulting from a relapse of acute myeloid leukemia after allogeneic cell transplantation in long-term survival of more than 10 years.Myeloid Sarcoma after Allogenic Stem Cell Transplantation for Acute Myeloid Leukemia: Successful Consolidation Treatment Approaches in Two Patients.
P2860
Q37344050-1CCC9F48-9C7D-4F57-808C-01220539F897Q37676299-8CED5040-7820-4924-AC5E-11330B7FC44AQ37905034-073E1E38-7719-45A4-B21D-0E8693C6BA79Q37937083-1C90E52A-A38A-419F-8E36-08C0056C6C61Q39667028-F4694A68-D099-4DDA-8229-4D4370B0728AQ41478883-A4B879AD-8BF5-4F17-8F15-073B4DB28F9AQ43263618-FD8F6E31-F281-4F6B-A44A-9205ED0903BAQ43893139-740BC83A-4562-4593-B53E-CEF59D97339CQ55252601-C6D32676-9755-4E76-99C2-CA7F2CE0CA70
P2860
Prospective trial of high-dose chemotherapy followed by infusions of peripheral blood stem cells and dose-escalated donor lymphocytes for relapsed leukemia after allogeneic stem cell transplantation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Prospective trial of high-dose ...... eic stem cell transplantation.
@en
Prospective trial of high-dose ...... eic stem cell transplantation.
@nl
type
label
Prospective trial of high-dose ...... eic stem cell transplantation.
@en
Prospective trial of high-dose ...... eic stem cell transplantation.
@nl
prefLabel
Prospective trial of high-dose ...... eic stem cell transplantation.
@en
Prospective trial of high-dose ...... eic stem cell transplantation.
@nl
P2093
P356
P1476
Prospective trial of high-dose ...... neic stem cell transplantation
@en
P2093
Hidesaku Asakura
Hirohito Yamazaki
Hirokazu Okumura
Koichiro Minauchi
Koki Kumano
Masahiro Kami
Mitsuyuki Nishio
Naomi Sugimori
Shigeru Shimadoi
P2888
P304
P356
10.1532/IJH97.05086
P577
2005-12-01T00:00:00Z
P6179
1018476024